Advancing HCC Surveillance:
The Clinical Case for Integrated
Risk Assessment
01 Jul 2026
Two real-world cases from Malaysian clinical practice illustrate potential gaps in current HCC surveillance approaches, where high-risk patients may remain difficult to detect using standard AFP and ultrasound monitoring alone. Dr Haniza Omar and Dr Syuhada Dan Adnan highlight GAAD score’s role in improving early HCC detection and imaging triggers.
Resources
MY-ROD-009: Advancing HCC Surveillance: The Clinical Case for Integrated Risk Assessment